title: Guidelines on chemotherapy in advanced stage gynecological malignancies: an evaluation of 224 professional societies and organizations.
abstract: BACKGROUND
  Clinical practice guidelines are important for guiding practice, but it is unclear if they are commensurate with the available evidence.
  
  
  METHODS
  We examined guidelines produced by cancer and gynecological societies and organizations and evaluated their coverage of and stance towards chemotherapy for advanced stage disease among 4 gynecological malignancies (breast, ovarian, cervical, endometrial cancer) where the evidence for the use of chemotherapy is very different (substantial and conclusive for breast and ovarian cancer, limited and suggesting no major benefit for cervical and endometrial cancer). Eligible societies and organizations were identified through systematic internet searches (last update June 2009). Pertinent websites were scrutinized for presence of clinical practice guidelines, and relative guidelines were analyzed.
  
  
  RESULTS
  Among 224 identified eligible societies and organizations, 69 (31%) provided any sort of guidelines, while recommendations for chemotherapy on advanced stage gynecological malignancies were available in 20 of them. Only 14 had developed their own guideline, and only 5 had developed guidelines for all 4 malignancies. Use of levels of evidence and grades of recommendations, and aspects of the production, implementation, and timeliness of the guidelines did not differ significantly across malignancies. Guidelines on breast and ovarian cancer utilized significantly more randomized trials and meta-analyses. Guidelines differed across malignancies on their coverage of disease-free survival (p = 0.033), response rates (p = 0.024), symptoms relief (p = 0.005), quality of life (p = 0.001) and toxicity (p = 0.039), with breast and ovarian cancer guidelines typically covering more frequently these outcomes. All guidelines explicitly or implicitly endorsed the use of chemotherapy.
  
  
  CONCLUSIONS
  Clinical practice guidelines are provided by the minority of professional societies and organizations. Available guidelines tend to recommend chemotherapy even for diseases where the effect of chemotherapy is controversial and recommendations are based on scant evidence.
authors: Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
authors: Nikolaos P
authors: NP
authors: Polyzos
authors: Davide
authors: D
authors: Mauri
authors: John P A
authors: JP
authors: Ioannidis
references: Lancet. 2001 Sep 8;358(9284):781-6
references: 11564482
references: J Natl Cancer Inst. 2008 Dec 17;100(24):1780-91
references: 19066278
references: Eur Spine J. 2006 May;15(5):543-53
references: 16217664
references: Lancet. 1997 Dec 13;350(9093):1752
references: 9413475
references: Pediatrics. 2005 May;115(5):1378-91
references: 15867050
references: Qual Saf Health Care. 2003 Dec;12(6):428-34
references: 14645758
references: Hum Reprod. 2008 Aug;23(8):1786-92
references: 18480089
references: Lancet. 2008 May 10;371(9624):1559-61
references: 18468530
references: J Clin Oncol. 2008 Dec 20;26(36):5994-6000
references: 19029413
references: BMJ. 2001 Jul 21;323(7305):155-7
references: 11463690
references: Ann Intern Med. 2002 Mar 5;136(5):403-6
references: 11874315
references: J Clin Epidemiol. 2002 Jun;55(6):545-55
references: 12063096
references: CMAJ. 2001 Jul 24;165(2):157-63
references: 11501454
references: JAMA. 2005 Jul 13;294(2):218-28
references: 16014596
references: Eur J Cancer. 2006 Feb;42(3):319-26
references: 16376072
references: JAMA. 1999 May 26;281(20):1900-5
references: 10349893
references: JAMA. 2005 Aug 10;294(6):716-24
references: 16091574
references: Cochrane Database Syst Rev. 2004;(2):CD001774
references: 15106161
references: JAMA. 2009 Feb 25;301(8):868-9
references: 19244197
references: Lancet. 2000 Jan 8;355(9198):103-6
references: 10675167
references: JAMA. 2007 Dec 26;298(24):2907-9
references: 18159060
references: JAMA. 2009 Feb 25;301(8):831-41
references: 19244190
references: Cancer Treat Rev. 2007 Feb;33(1):24-38
references: 17112673
references: Chest. 1998 Mar;113(3 Suppl):166S-171S
references: 9515887
references: J Clin Oncol. 2008 Aug 20;26(24):4022-6
references: 18711193
references: Ann Intern Med. 2002 Jun 18;136(12):888-95
references: 12069563
references: JAMA. 2007 Dec 12;298(22):2668-70
references: 18073363
references: Chest. 2003 Jan;123(1 Suppl):7S-20S
references: 12527562
references: JAMA. 2009 Apr 1;301(13):1367-72
references: 19336712
references: Open Med. 2009 May 26;3(2):e62-8
references: 19946395
references: J Natl Cancer Inst. 2006 Nov 15;98(22):1655-63
references: 17105988
references: BMJ. 1999 Feb 20;318(7182):527-30
references: 10024268